...
机译:实验性恶性胸腔积液的产生取决于人肺癌细胞对胸膜的侵袭和血管内皮生长因子/血管通透性因子的表达
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
From the Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas;
机译:ZD6474是血管内皮生长因子受体酪氨酸激酶的抑制剂,可在非小细胞肺癌模型中抑制实验性肺转移的生长和恶性胸腔积液的产生。
机译:血浆和胸腔积液中的血管内皮生长因子是贝伐单抗联合卡铂-紫杉醇治疗恶性胸腔积液非小细胞肺癌后结果的生物标志物。
机译:肺腺癌伴恶性胸腔积液的血管内皮生长因子和可溶性细胞间粘附分子-1:与患者生存率和胸腔积液控制的关系。
机译:用于血管内皮生长因子治疗的内皮细胞蛋白质提取物的微丙酰上的LC分级
机译:血管内皮生长因子/血管通透性因子的特定替代剪接变体在小鼠多阶段皮肤癌变中的作用。
机译:实验性恶性胸腔积液的产生取决于人肺癌细胞对胸膜的侵袭和血管内皮生长因子/血管通透性因子的表达
机译:实验性恶性胸腔积液的产生取决于人肺癌细胞对胸膜的侵袭和血管内皮生长因子/血管通透性因子的表达